Study on The FAM180B Gene and Its Potential as A Drug Target Or Biomarker

Target Name: FAM180B

NCBI ID: G399888

FAM180B

Study on The FAM180B Gene and Its Potential as A Drug Target Or Biomarker

The FAM180B gene, also known as FAM180B1, is a member of the FAM180 gene family, which encodes a protein involved in various cellular processes. The FAM180B protein has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration and invasion, and has potential as a drug target or biomarker.

The FAM180B gene was first identified in the genomic sequence database by bioinformatic analysis of gene expression data. The gene was later isolated and cloned into a plasmid, which was used to create a cDNA library. The cDNA library was then used to generate RNA transcripts, which were used to create a DNA template for PCR amplification. The DNA template was then used to create a plasmid, which was used to express the FAM180B protein in cells.

To study the function of the FAM180B protein, researchers used a variety of techniques, including qRT-PCR, western blotting and live cell imaging. They found that the FAM180B protein was expressed in various tissues and cells, including the brain, spinal cord, and gastrointestinal tract. The protein was also shown to localize to the endoplasmic reticulum (ER) and to be involved in the regulation of the ER-associated degradation pathway (ERAD).

In addition to its role in ERAD regulation, the FAM180B protein has also been shown to play a role in the regulation of cell adhesion and migration. Researchers used cell-based assays to show that the FAM180B protein can inhibit the migration of cancer cells along the vascular endothelial growth factor (VEGF) gradient. This suggests that the FAM180B protein may have potential as a therapeutic agent for cancer treatment.

The FAM180B protein has also been shown to play a role in the regulation of cell signaling pathways. Researchers used mass spectrometry to identify a number of protein-protein interactions that are involved in the regulation of the PI3K/Akt signaling pathway. This suggests that the FAM180B protein may be a useful biomarker for the diagnosis and treatment of diseases associated with PI3K/Akt signaling pathway dysfunction.

In conclusion, the FAM180B gene is a promising drug target and biomarker due to its involvement in various cellular processes. The FAM180B protein has been shown to play a role in the regulation of cell adhesion, migration and invasion, and in the regulation of cell signaling pathways. Further research is needed to fully understand the function of the FAM180B protein and its potential as a therapeutic agent.

Protein Name: Family With Sequence Similarity 180 Member B

The "FAM180B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM180B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets